Effects of metastasectomy and other factors on survival of patients with ovarian metastases from gastric cancer: a systematic review and meta-analysis

被引:16
作者
Zhang, Chao [1 ,2 ]
Hou, Wenbin [1 ,2 ]
Huang, Jinyu [1 ,2 ]
Yin, Songcheng [1 ,2 ]
Wang, Pengliang [1 ,2 ]
Zhang, Zhe [1 ,2 ]
Tan, Yuen [1 ,2 ]
Xu, Huimian [1 ,2 ]
机构
[1] China Med Univ, Dept Surg Oncol, Affiliated Hosp 1, Shenyang 110001, Liaoning, Peoples R China
[2] Key Lab Gastr Canc Mol Pathol Liaoning Prov, 155 Nanjing North St, Shenyang 110001, Liaoning, Peoples R China
基金
中国国家自然科学基金;
关键词
Gastric cancer; Krukenberg tumor; Meta-analysis; Metastasectomy; Prognosis; KRUKENBERG TUMORS; PROGNOSTIC-FACTORS; CYTOREDUCTIVE SURGERY; CLINICOPATHOLOGICAL CHARACTERISTICS; RECURRENCE; RESECTION; ESTROGEN; EXPRESSION; RISK; BIAS;
D O I
10.1002/jcb.28708
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Ovarian metastasis from gastric cancer (Krukenberg tumor [KT]) has no consensus treatment and the role of surgical treatment is still controversial. Identifying prognostic factors for KT could help guide the management of this tumor. We used a meta-analysis to evaluate the prognostic value of metastasectomy and other factors in patients with KT to develop a treatment plan. We searched literature in PubMed, Cochrane library and EMBASE. We analyzed hazard ratios (HR) and 95% confidence intervals (CI) with respect to overall survival (OS). The meta-analysis included 12 cohort studies with 1,031 patients associated with longer OS following metastasectomy (HR = 0.41; 95% CI = 0.32-0.53; P < 0.001), R0 resection (HR = 0.37; 95% CI = 0.26-0.53; P < 0.001), metachronous ovarian metastasis (HR = 0.74; 95% CI = 0.58-0.93; P = 0.012), size of KT (<5 cm) (HR = 0.74; 95% CI = 0.58-0.95; P = 0.019), ECOG PS (Eastern Cooperative Oncology Group performance status) 0 to 1 (HR = 0.48; 95% CI = 0.29-0.80; P = 0.004), tumor confined to ovary (HR = 0.40; 95% CI = 0.16-0.99; P = 0.047), and tumor confined to pelvic cavity (HR = 0.36; 95% CI = 0.14-0.92; P = 0.033). Shorter OS was associated with peritoneal carcinomatosis (HR = 2.00; 95% CI = 1.25-3.21; P = 0.004), ascites (HR = 1.66; 95% CI = 1.19-2.31; P = 0.003) and positive CEA (HR = 1.41; 95% CI = 1.10-1.82; P = 0.007). Gastrectomy led to a slight improvement in OS, but without statistical significance (HR = 0.69; 95% CI = 0.47-1.02; P = 0.061). No significant difference in OS was observed in patients with signet-ring cells (HR = 1.17; 95% CI = 0.91-1.51; P = 0.226), bilateral ovarian metastasis (HR = 0.87; 95% CI = 0.70-1.08; P = 0.212), age >= 50 years (HR = 0.93; 95% CI = 0.71-1.22; P = 0.619), positive CA19-9 (HR = 1.01; 95% CI = 0.75-1.35; P = 0.960), and positive CA-125 (HR = 0.98; 95% CI = 0.73-1.33; P = 0.915). Various factors affect OS in patients with KT.
引用
收藏
页码:14486 / 14498
页数:13
相关论文
共 48 条
[1]   Krukenberg tumors: Seed, route and soil [J].
Agnes, Annamaria ;
Biondi, Alberto ;
Ricci, Riccardo ;
Gallotta, Valerio ;
D'Ugo, Domenico ;
Persiani, Roberto .
SURGICAL ONCOLOGY-OXFORD, 2017, 26 (04) :438-445
[2]   The role of cytoreductive surgery in nongenital cancers metastatic to the ovaries [J].
Ayhan, A ;
Guvenal, T ;
Salman, MC ;
Ozyuncu, O ;
Sakinci, M ;
Basaran, M .
GYNECOLOGIC ONCOLOGY, 2005, 98 (02) :235-241
[3]   OPERATING CHARACTERISTICS OF A BANK CORRELATION TEST FOR PUBLICATION BIAS [J].
BEGG, CB ;
MAZUMDAR, M .
BIOMETRICS, 1994, 50 (04) :1088-1101
[4]   Efficacy of modern chemotherapy and prognostic factors in patients with ovarian metastases from gastric cancer: A retrospective AGEO multicentre study [J].
Brieau, Bertrand ;
Auzolle, Claire ;
Pozet, Astrid ;
Tougeron, David ;
Bouche, Olivier ;
Soibinet, Pauline ;
Coriat, Romain ;
Prieux, Caroline ;
Lecomte, Thierry ;
Goujon, Gael ;
Marthey, Lysiane ;
Rougier, Philippe ;
Bonnetain, Franck ;
Ducreux, Michel ;
Taieb, Julien ;
Zaanan, Aziz .
DIGESTIVE AND LIVER DISEASE, 2016, 48 (04) :441-445
[5]   Oestrogen and the enigmatic male predominance of gastric cancer [J].
Chandanos, Evangelos ;
Lagergren, Jesper .
EUROPEAN JOURNAL OF CANCER, 2008, 44 (16) :2397-2403
[6]   Survival benefit of metastasectomy for Krukenberg tumors from gastric cancer [J].
Cheong, JH ;
Hyung, WJ ;
Chen, J ;
Kim, J ;
Choi, SH ;
Noh, SH .
GYNECOLOGIC ONCOLOGY, 2004, 94 (02) :477-482
[7]   Surgical management and outcome of Metachronous Krukenberg tumors from gastric cancer [J].
Cheong, JH ;
Hyung, WJ ;
Chen, J ;
Kim, J ;
Choi, SH ;
Noh, SH .
JOURNAL OF SURGICAL ONCOLOGY, 2004, 87 (01) :39-45
[8]   Gene Expression Signature-Based Prognostic Risk Score in Gastric Cancer [J].
Cho, Jae Yong ;
Lim, Jae Yun ;
Cheong, Jae Ho ;
Park, Yun-Yong ;
Yoon, Se-Lyun ;
Kim, Soo Mi ;
Kim, Sang-Bae ;
Kim, Hoguen ;
Hong, Soon Won ;
Park, Young Nyun ;
Noh, Sung Hoon ;
Park, Eun Sung ;
Chu, In-Sun ;
Hong, Waun Ki ;
Ajani, Jaffer A. ;
Lee, Ju-Seog .
CLINICAL CANCER RESEARCH, 2011, 17 (07) :1850-1857
[9]   Comparison of Surgery Plus Chemotherapy and Palliative Chemotherapy Alone for Advanced Gastric Cancer with Krukenberq Tumor [J].
Cho, Jang Ho ;
Lim, Jae Yun ;
Choi, Ah Ran ;
Choi, Sung Min ;
Kim, Jong Won ;
Choi, Seung Ho ;
Cho, Jae Yong .
CANCER RESEARCH AND TREATMENT, 2015, 47 (04) :697-705
[10]   Investigation of the recurrence patterns of gastric cancer following a curative resection [J].
Deng, Jingyu ;
Liang, Han ;
Wang, Dianchang ;
Sun, Dan ;
Pan, Yi ;
Liu, Yong .
SURGERY TODAY, 2011, 41 (02) :210-215